RxNorm 1597099
GARDASIL 9 0.5 ML Injection
RxNorm Semantic Concepts
RxNorm semantic concepts for the RxCUI 1597099 unique identifier include: GARDASIL 9 0.5 ML Injection (6836570), 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9] (12361409) and Gardasil 9, Human Papillomavirus 9-valent (Types 6,11,16,18,31,33,45,52,58) Vaccine, Recombinant 0.5 ML Injection (7250532).
RxNorm Atom ID: 6836570 - Prescribable Name
GARDASIL 9 0.5 ML Injection
- RXCUI:
- 1597099 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 6836570 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- GARDASIL 9 0.5 ML Injection - Description of concept identifier
- Term Type (TTY):
- PSN - Term type in source with name and description
- Term Type Name:
- Prescribable Name - Name of term type in source
- Term Type Description:
- Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. - Description of term type in source
- Code:
- 1597099 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom ID: 12361409 - Semantic Branded Drug
0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9]
- RXCUI:
- 1597099 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 12361409 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- 0.5 ML L1 protein, human papillomavirus type 11 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 16 vaccine 0.12 MG/ML / L1 protein, human papillomavirus type 18 vaccine 0.08 MG/ML / L1 protein, human papillomavirus type 31 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 33 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 45 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 52 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 58 vaccine 0.04 MG/ML / L1 protein, human papillomavirus type 6 vaccine 0.06 MG/ML Injection [Gardasil 9] - Description of concept identifier
- Term Type (TTY):
- SBD - Term type in source with name and description
- Term Type Name:
- Semantic Branded Drug - Name of term type in source
- Term Type Description:
- Ingredient + Strength + Dose Form + Brand Name - Description of term type in source
- Code:
- 1597099 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
RxNorm Atom 12361409 Attributes
| Property | Value | Explanation |
|---|---|---|
| RXN AI | {1597083} 798264 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
| RXN AI | {1597084} 798266 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
| RXN AI | {1597085} 1596930 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
| RXN AI | {1597086} 1596931 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
| RXN AI | {1597087} 1596932 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
| RXN AI | {1597088} 1596933 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
| RXN AI | {1597089} 1596934 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
| RXN AI | {1597090} 798268 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
| RXN AI | {798263} 798262 | RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value |
| RXN AM | {1597083} 798264 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
| RXN AM | {1597084} 798266 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
| RXN AM | {1597085} 1596930 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
| RXN AM | {1597086} 1596931 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
| RXN AM | {1597087} 1596932 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
| RXN AM | {1597088} 1596933 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
| RXN AM | {1597089} 1596934 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
| RXN AM | {1597090} 798268 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
| RXN AM | {798263} 798262 | RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value |
| RXN AVAILABLE STRENGTH | 0.08 MG/ML / 0.12 MG/ML / 0.08 MG/ML / 0.04 MG/ML / 0.04 MG/ML / 0.04 MG/ML / 0.04 MG/ML / 0.04 MG/ML / 0.06 MG/ML | Available drug strengths listed in the order of ingredients from the drug |
| RXN BOSS FROM | {1597083} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
| RXN BOSS FROM | {1597084} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
| RXN BOSS FROM | {1597085} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
| RXN BOSS FROM | {1597086} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
| RXN BOSS FROM | {1597087} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
| RXN BOSS FROM | {1597088} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
| RXN BOSS FROM | {1597089} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
| RXN BOSS FROM | {1597090} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
| RXN BOSS FROM | {798263} AI | Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value |
| RXN HUMAN DRUG | US | Drug available for use in Humans |
| RXN QUANTITY | 0.5 ML | Normal Form quantity factor |
RxNorm Atom ID: 7250532 - Synonym
Gardasil 9, Human Papillomavirus 9-valent (Types 6,11,16,18,31,33,45,52,58) Vaccine, Recombinant 0.5 ML Injection
- RXCUI:
- 1597099 - RxNorm Unique Identifier for a concept (Concept ID)
- LAT:
- ENG - Language of the Term
- RXAUI:
- 7250532 - Unique identifier for the atom (RxNorm Atom ID)
- Is Prescribable?
- YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
- Concept Description:
- Gardasil 9, Human Papillomavirus 9-valent (Types 6,11,16,18,31,33,45,52,58) Vaccine, Recombinant 0.5 ML Injection - Description of concept identifier
- Term Type (TTY):
- SY - Term type in source with name and description
- Term Type Name:
- Synonym - Name of term type in source
- Term Type Description:
- Synonym of another TTY, given for clarity. - Description of term type in source
- Code:
- 1597099 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
- Suppress Flag:
- N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility. - CVF:
- 4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
- Source:
- RXNORM - Concept source abbreviation
- Source Name:
- RxNorm Vocabulary - The official name for a source
- Source Version:
- 20AA_240401F - The source version
- Source Date:
- March 04, 2024 - RxNorm data last updated
- Source License Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information - Source Content Contact:
- RxNorm Customer Service
U.S. National Library of Medicine
8600 Rockville Pike
Bethesda
MD
United States
20894
(888) FIND-NLM
[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information - Source Short Name:
- RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server
* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Patient Education
Human Papillomavirus (HPV) Vaccine
Why get vaccinated? HPV vaccine prevents infection with human papillomavirus (HPV) types that are associated with cause many cancers, including the following: cervical cancer in females vaginal and vulvar cancers in females anal cancer in females and males throat cancer in females and males penile cancer in males In addition, HPV vaccine prevents infection with HPV types that cause genital warts in both females and males. In the United States, about 12,000 women get cervical cancer every year, and about 4,000 women die from it. HPV vaccine can prevent most of these cases of cervical cancer. Vaccination is not a substitute for cervical cancer screening. This vaccine does not protect against all HPV types that can cause cervical cancer. Women should still get regular Pap tests. HPV infection usually comes from sexual contact, and most people will become infected at some point in their life. About 14 million Americans, including teens, get infected every year. Most infections will go away on their own and not cause serious problems. But thousands of women and men get cancer and other diseases from HPV.
[Learn More]
* Please review the disclaimer below.